These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 182963)

  • 1. Proceedings: Prostaglandins as possible mediators of tumour-induced bone resorption.
    Atkins D; Hunt NH; Martin TJ; Michelangeli VP
    J Physiol; 1976 Jul; 259(1):7P-9P. PubMed ID: 182963
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cyclic AMP, calcium, and prostaglandins in the induction of osteoclastic bone resorption associated with experimental tooth movement.
    Yamasaki K
    J Dent Res; 1983 Aug; 62(8):877-81. PubMed ID: 6306082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A revised role for cyclic AMP in prostaglandin-induced bone resorption.
    Lerner U; Gustafson GT
    Med Biol; 1980 Feb; 58(1):18-24. PubMed ID: 6247586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
    Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
    Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria.
    Gardner CR; Blanqué R; Cottereaux C
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):117-25. PubMed ID: 11237479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin, thromboxanes, and hematogenous metastasis.
    Honn KV; Sloane BF
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():313-8. PubMed ID: 6221609
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies of bone formation and resorption.
    Heersche JN
    Clin Invest Med; 1982; 5(2-3):173-8. PubMed ID: 6288302
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostaglandins--local regulators in bone?].
    Bartels T; Hein W; Taube C; Mest HJ
    Beitr Orthop Traumatol; 1989 Aug; 36(8):345-9. PubMed ID: 2679538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
    Weiss J; Walker ST; Fallon M; Goldfarb S
    J Pharmacol Exp Ther; 1986 Sep; 238(3):969-73. PubMed ID: 3018229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of bone resorption and hypercalcemia in cancer.
    Pugliese G
    N Engl J Med; 1988 Mar; 318(10):642-3. PubMed ID: 3344013
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotactic responses of tumor cells to products of resorbing bone.
    Orr W; Varani J; Gondex MK; Ward PA; Mundy GR
    Science; 1979 Jan; 203(4376):176-9. PubMed ID: 569363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro.
    Ljunggren O; Ljunghall S
    Biochem Biophys Res Commun; 1993 Jun; 193(3):821-6. PubMed ID: 8391806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone.
    Magro C; Orr FW; Manishen WJ; Sivananthan K; Mokashi SS
    J Natl Cancer Inst; 1985 Apr; 74(4):829-38. PubMed ID: 3857380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of osteoclasia in rats with Walker tumor.
    Schäfer A; Raue F; Minne H; Ziegler R
    Calcif Tissue Res; 1977 May; 22 Suppl():368-70. PubMed ID: 912548
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of cyclic AMP and prostaglandins in morphine analgesia, tolerance and physical dependence.
    Meisheri KD
    Indian J Physiol Pharmacol; 1978; 22(4):339-46. PubMed ID: 220194
    [No Abstract]   [Full Text] [Related]  

  • 16. An appraisal of the interrelationships between prostaglandins and cyclic nucleotides in inflammation.
    Dunn CJ; Willoughby DA; Giroud JP; Yamamoto S
    Biomedicine; 1976; 24(4):214-20. PubMed ID: 186134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
    Farsoudi KH; Pietschmann P; Cross HS; Peterlik M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):579-83. PubMed ID: 8382276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--prostaglandins and related substances].
    Nagata N
    Nihon Rinsho; 1986 Nov; 44(11):2385-90. PubMed ID: 3546789
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Newcomer SF
    Cancer Res; 1977 Dec; 37(12):4493-9. PubMed ID: 200352
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of prostaglandins in the regulation of bone metabolism.
    Kawaguchi H; Pilbeam CC; Harrison JR; Raisz LG
    Clin Orthop Relat Res; 1995 Apr; (313):36-46. PubMed ID: 7641496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.